Category: Cancer Treatment
Cancer Treatment market research reports by Icon Group International, Inc.
-
The 2025-2030 World Outlook for Liposomal Doxorubicin
The 2025-2030 World Outlook for Liposomal Doxorubicin This study covers the world outlook for liposomal doxorubicin across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of ... Read More
-
The 2025-2030 World Outlook for Photodynamic Therapies
The 2025-2030 World Outlook for Photodynamic Therapies This study covers the world outlook for photodynamic therapies across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions o ... Read More
-
The 2025-2030 World Outlook for Chronic Lymphocytic Leukemia
The 2025-2030 World Outlook for Chronic Lymphocytic Leukemia This study covers the world outlook for chronic lymphocytic leukemia across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (i ... Read More
-
The 2025-2030 World Outlook for Leukemia Therapeutics
The 2025-2030 World Outlook for Leukemia Therapeutics This study covers the world outlook for leukemia therapeutics across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of ... Read More
-
The 2025-2030 World Outlook for Women's Diagnostic Breast Cancer Testing
The 2025-2030 World Outlook for Women's Diagnostic Breast Cancer Testing This study covers the world outlook for women's diagnostic breast cancer testing across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for th ... Read More
-
The 2025-2030 World Outlook for PDX Models
The 2025-2030 World Outlook for PDX Models This study covers the world outlook for PDX models across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the per ... Read More
-
The 2025-2030 World Outlook for HER-2 Positive Breast Cancer Chemotherapy
The 2025-2030 World Outlook for HER-2 Positive Breast Cancer Chemotherapy This study covers the world outlook for HER-2 positive breast cancer chemotherapy across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for ... Read More
-
The 2025-2030 World Outlook for Lung Cancer Screening Software
The 2025-2030 World Outlook for Lung Cancer Screening Software This study covers the world outlook for lung cancer screening software across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in questio ... Read More
-
The 2025-2030 World Outlook for Hormone Therapy for Prostate Cancer Therapeutics
The 2025-2030 World Outlook for Hormone Therapy for Prostate Cancer Therapeutics This study covers the world outlook for hormone therapy for prostate cancer therapeutics across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings ... Read More
-
The 2025-2030 World Outlook for Multiple Myeloma Treatments
The 2025-2030 World Outlook for Multiple Myeloma Treatments This study covers the world outlook for multiple myeloma treatments across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in ... Read More
-
The 2025-2030 World Outlook for NDDS in Cancer Therapies
The 2025-2030 World Outlook for NDDS in Cancer Therapies This study covers the world outlook for NDDS in cancer therapies across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millio ... Read More
-
The 2025-2030 World Outlook for Colorectal Cancer Drugs
The 2025-2030 World Outlook for Colorectal Cancer Drugs This study covers the world outlook for colorectal cancer drugs across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions ... Read More
-
The 2025-2030 World Outlook for Breast Cancer Treatments
The 2025-2030 World Outlook for Breast Cancer Treatments This study covers the world outlook for breast cancer treatments across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millio ... Read More
-
The 2025-2030 World Outlook for Checkpoint Inhibitors for Anti-Cancer Treatments
The 2025-2030 World Outlook for Checkpoint Inhibitors for Anti-Cancer Treatments This study covers the world outlook for checkpoint inhibitors for anti-cancer treatments across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings ... Read More
-
The 2025-2030 World Outlook for Cancer Profiling Technologies
The 2025-2030 World Outlook for Cancer Profiling Technologies This study covers the world outlook for cancer profiling technologies across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question ... Read More
-
The 2025-2030 World Outlook for Microwave Ablations
The 2025-2030 World Outlook for Microwave Ablations This study covers the world outlook for microwave ablations across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. ... Read More
-
The 2025-2030 World Outlook for Cancer Gene Therapies
The 2025-2030 World Outlook for Cancer Gene Therapies This study covers the world outlook for cancer gene therapies across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of ... Read More
-
The 2025-2030 World Outlook for Cancer Biomarkers
The 2025-2030 World Outlook for Cancer Biomarkers This study covers the world outlook for cancer biomarkers across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dol ... Read More
-
The 2025-2030 World Outlook for In-Vitro Colorectal Cancer Screening Tests
The 2025-2030 World Outlook for In-Vitro Colorectal Cancer Screening Tests This study covers the world outlook for in-vitro colorectal cancer screening tests across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), fo ... Read More
-
The 2025-2030 World Outlook for Orphan Cancer Drugs
The 2025-2030 World Outlook for Orphan Cancer Drugs This study covers the world outlook for orphan cancer drugs across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. ... Read More
-
The 2025-2030 World Outlook for Circulating Tumor Cells
The 2025-2030 World Outlook for Circulating Tumor Cells This study covers the world outlook for circulating tumor cells across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions ... Read More
-
The 2025-2030 World Outlook for NDDS for Cancer Therapies
The 2025-2030 World Outlook for NDDS for Cancer Therapies This study covers the world outlook for NDDS for cancer therapies across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in mill ... Read More
-
The 2025-2030 World Outlook for Neuroendocrine Tumors
The 2025-2030 World Outlook for Neuroendocrine Tumors This study covers the world outlook for neuroendocrine tumors across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of ... Read More
-
The 2025-2030 World Outlook for T-Cell Immunotherapies
The 2025-2030 World Outlook for T-Cell Immunotherapies This study covers the world outlook for t-cell immunotherapies across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions o ... Read More
-
The 2025-2030 World Outlook for Novel Drug Delivery Systems in Cancer Therapies
The 2025-2030 World Outlook for Novel Drug Delivery Systems in Cancer Therapies This study covers the world outlook for novel drug delivery systems in cancer therapies across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P ... Read More
Research Assistance
